Morgan Stanley lowered the firm’s price target on Nike (NKE) to $70 from $72 and keeps an Equal Weight rating on the shares. While Nike’s quarterly results came in better-than-expected, the sequentially worsening Q4 guidance and expectations for a trend improvement in the first half of 2026 leaves the firm convicted in its pre-print view that EPS risk likely lingers into FY26, the analyst tells investors in a research note. Management’s initiatives are on the right track, but the road from here is long and volatile, the firm says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKE:
- Nike price target lowered to $66 from $73 at UBS
- Nike’s Long-Term Growth Potential Amid Inventory Challenges: A Buy Rating
- Nike Inc. Reports Decline in Q3 2025 Earnings
- Nike’s Q3 Outperformance Overshadowed by Weaker Q4 Guidance and Valuation Concerns
- Closing Bell Movers: Nike falls to pandemic onset lows as guidance disappoints